Skip to content

KLRS KLRS Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Merck & Co. logo
Merck & Co.MRK
-$4.24B-183%
Amgen logo
AmgenAMGN
$1.82B+5.1%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-$84.83M-87.7%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$88.61M-38.3%

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's net income?
KLRS (KLRS) reported net income of -$10.86M in Q1 2026.
How has KLRS's net income changed year-over-year?
KLRS's net income decreased by 6.5% year-over-year, from -$10.2M to -$10.86M.
What is the long-term trend for KLRS's net income?
Over 3 years (2021 to 2025), KLRS's net income has grown at a -36.8% compound annual growth rate (CAGR), from -$171.96M to -$43.44M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.